Dr. Sarah-Jane Maertens SRL
Dr. Sarah-Jane Maertens reported total assets of 187,448 € at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Mar 2026).
The score of Dr. Sarah-Jane Maertens shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +454 % Total assets +277 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Sarah-Jane Maertens's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 22 Mar 2026
- Year ended 30 Sep 2024filed on 24 Mar 2025
- Year ended 30 Sep 2023filed on 12 Apr 2024
Dr. Sarah-Jane Maertens's financial analysis
- Solvency87.8%sector median: 72.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Sarah-Jane Maertens
Dr. Sarah-Jane Maertens's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0799.976.816
- VAT number
- BE0799976816
- Peppol
- Registered · 0208:0799976816 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Mar 2023
- Registered office
- 8870 Izegem
- Latest accounts
- 2025 · filed on 22 Mar 2026
- Activity
- General medical practice activities (NACE 86210)
Dr. Sarah-Jane Maertens (SRL) has been based in Izegem since 2023, active in: general medical practice activities. For 2025, it reports a net profit of 75,298 € and equity of 164,635 €; its revenue is not published. Its solvency stands at 87.8%, above the median of its sector (72.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Sarah-Jane Maertens
Companies in the same business, of comparable size and area, outside its group.
- Dr. Nouwynck Lore General medical practice activities Waregem · balance sheet 187,400 €
- Dr. L. Vander Stichele General medical practice activities Roeselare · balance sheet 195,036 €
- Dokter Vanduynslager Tine General medical practice activities Roeselare · balance sheet 195,040 €
- Sacura General medical practice activities Dentergem · balance sheet 195,129 €
- DR Coussement Bernard General medical practice activities Roeselare · balance sheet 196,334 €
- Dr. Julie Deleersnyder General medical practice activities Izegem · balance sheet 177,797 €
- Huisarts dokter Diewke Bageart General medical practice activities Wielsbeke · balance sheet 177,415 €
- Dr. Merijn Degrave General medical practice activities Kortrijk · balance sheet 201,450 €
Frequently asked questions about Dr. Sarah-Jane Maertens
What is the revenue of Dr. Sarah-Jane Maertens?
Dr. Sarah-Jane Maertens files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Sarah-Jane Maertens?
In Belgium, the VAT number is the company number prefixed with BE: BE0799976816 for Dr. Sarah-Jane Maertens, if the company is VAT-registered. Its company number (CBE) is 0799.976.816.
Where is the registered office of Dr. Sarah-Jane Maertens?
According to the CBE register, the registered office of Dr. Sarah-Jane Maertens is in 8870 Izegem.
What is the equity of Dr. Sarah-Jane Maertens?
At the close of the 2025 financial year, the equity of Dr. Sarah-Jane Maertens amounts to 164,635 €, a solvency of 87.8% of total assets.
Who manages Dr. Sarah-Jane Maertens?
The register lists 1 active mandates at Dr. Sarah-Jane Maertens. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. Sarah-Jane Maertens
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →